• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C 反应蛋白水平可预测 SARS-CoV2 感染孕妇是否需要医疗干预:一项回顾性研究。

C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study.

机构信息

Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Department of Respiratory Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

J Obstet Gynaecol Res. 2022 Apr;48(4):938-945. doi: 10.1111/jog.15181. Epub 2022 Feb 15.

DOI:10.1111/jog.15181
PMID:35170165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9115179/
Abstract

AIM

To make effective use of the limited available hospital space during the Coronavirus disease 2019 (COVID-19) pandemic, we conducted this study to investigate the laboratory indices that identify pregnant women with SARS-CoV2 infection who require medical intervention.

METHODS

We carried out a retrospective analysis of pregnant women positive for COVID-19 who were admitted to Hokkaido University Hospital from September 2020 to June 2021. Medical interventions included oxygen supplementation, systemic corticosteroids, or supplemental liquids to treat infection-related symptoms.

RESULTS

Forty-two infected pregnant patients were admitted to the hospital, half of whom required medical intervention (n = 21). Fever, C-reactive protein (CRP), and platelet count are all associated with need for medical intervention. Of the 32 patients with a fever of ≥37.5°C on days 0-3 after onset of syndromes, 22 (69%) continued to have a fever on days 4-6, of which 19 (86.4%) required medical intervention. CRP level on days 4-6 predicted the presence or absence of medical intervention (area under the receiver operating characteristic curve = 0.913), with a sensitivity of 81% and specificity of 100% at a CRP cutoff of 1.28 mg/dL.

CONCLUSIONS

The need for medical intervention in pregnant patients can be predicted with high accuracy using a CRP cutoff of 1.28 mg/dL on days 4-6 after onset of syndromes. The presence of fever also may be an easy marker for selecting subjects who need or will need therapeutic intervention. These could be an effective triage method to determine appropriate indications for the hospitalization of pregnant women in future outbreaks.

摘要

目的

在 2019 年冠状病毒病(COVID-19)大流行期间,为了有效利用有限的医院空间,我们进行了这项研究,以调查识别需要医疗干预的 SARS-CoV2 感染孕妇的实验室指标。

方法

我们对 2020 年 9 月至 2021 年 6 月期间入住北海道大学医院的 COVID-19 阳性孕妇进行了回顾性分析。医疗干预包括吸氧、全身皮质类固醇或补充液体以治疗与感染相关的症状。

结果

42 名感染孕妇住院,其中一半需要医疗干预(n=21)。发热、C 反应蛋白(CRP)和血小板计数均与需要医疗干预有关。在症状出现后 0-3 天内发热≥37.5°C 的 32 名患者中,22 名(69%)在 4-6 天仍有发热,其中 19 名(86.4%)需要医疗干预。4-6 天的 CRP 水平预测是否需要医疗干预(受试者工作特征曲线下面积=0.913),CRP 截断值为 1.28mg/dL 时,灵敏度为 81%,特异性为 100%。

结论

在症状出现后 4-6 天,使用 CRP 截断值 1.28mg/dL 可以高度准确地预测孕妇是否需要医疗干预。发热的存在也可能是选择需要或将要接受治疗干预的患者的一个简单标志物。这可能是一种有效的分诊方法,以确定在未来疫情中孕妇住院的适当指征。

相似文献

1
C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study.C 反应蛋白水平可预测 SARS-CoV2 感染孕妇是否需要医疗干预:一项回顾性研究。
J Obstet Gynaecol Res. 2022 Apr;48(4):938-945. doi: 10.1111/jog.15181. Epub 2022 Feb 15.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Letter to "C-reactive protein level predicts need for medical intervention in pregnant women with SARS-CoV2 infection: A retrospective study".致《C反应蛋白水平预测新冠病毒感染孕妇的医学干预需求:一项回顾性研究》
J Obstet Gynaecol Res. 2022 May;48(5):1285-1286. doi: 10.1111/jog.15207. Epub 2022 Mar 10.
5
Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.羟氯喹预防 SARS-CoV-2 感染和妊娠期 COVID-19 疾病严重程度的疗效和安全性(COVID-Preg):一项随机安慰剂对照试验研究方案的结构化总结。
Trials. 2020 Jul 2;21(1):607. doi: 10.1186/s13063-020-04557-y.
6
Clinical course of coronavirus disease-2019 in pregnancy.妊娠期 2019 冠状病毒病的临床病程。
Acta Obstet Gynecol Scand. 2020 Jul;99(7):839-847. doi: 10.1111/aogs.13921. Epub 2020 Jun 10.
7
An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.针对有症状孕妇的重症 COVID-19 感染和入住重症监护病房的内部验证预测模型。
Am J Obstet Gynecol. 2022 Mar;226(3):403.e1-403.e13. doi: 10.1016/j.ajog.2021.09.024. Epub 2021 Sep 25.
8
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.一项评估巴瑞替尼预防 COVID19 相关血液肿瘤患者呼吸功能不全进展的疗效的 I/II 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2.与感染 SARS-CoV-2 的非孕妇相比,孕妇的实验室特征。
Arch Gynecol Obstet. 2020 Sep;302(3):629-634. doi: 10.1007/s00404-020-05655-7. Epub 2020 Jun 22.

引用本文的文献

1
Predicting Intensive Care Unit Admission in COVID-19-Infected Pregnant Women Using Machine Learning.使用机器学习预测COVID-19感染孕妇的重症监护病房入院情况。
J Clin Med. 2024 Dec 17;13(24):7705. doi: 10.3390/jcm13247705.
2
The Utilization and Interpretation of Cardiac Biomarkers During Pregnancy: Expert Panel.孕期心脏生物标志物的应用与解读:专家小组
JACC Adv. 2022 Aug 26;1(3):100064. doi: 10.1016/j.jacadv.2022.100064. eCollection 2022 Aug.
3
Management of COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS) During Pregnancy Following In Vitro Fertilization (IVF).体外受精(IVF)后孕期新冠病毒 2019 相关急性呼吸窘迫综合征(ARDS)的管理
Cureus. 2024 Mar 29;16(3):e57223. doi: 10.7759/cureus.57223. eCollection 2024 Mar.
4
Association of D-Dimer, C-Reactive Protein, and Ferritin with COVID-19 Severity in Pregnant Women: Important Findings of a Cross-Sectional Study in Northern Brazil.D-二聚体、C 反应蛋白和铁蛋白与孕妇 COVID-19 严重程度的相关性:巴西北部一项横断面研究的重要发现。
Int J Environ Res Public Health. 2023 Jul 20;20(14):6415. doi: 10.3390/ijerph20146415.
5
Pregnancy Outcomes, Immunophenotyping and Immunohistochemical Findings in a Cohort of Pregnant Patients with COVID-19-A Prospective Study.新冠病毒疾病(COVID-19)感染孕妇队列的妊娠结局、免疫表型及免疫组化结果——一项前瞻性研究
Diagnostics (Basel). 2023 Apr 4;13(7):1345. doi: 10.3390/diagnostics13071345.
6
Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management.生物标志物(sFlt-1/PlGF)在 COVID-19 病例中的作用,用于鉴别子痫前期并指导临床管理。
Pregnancy Hypertens. 2023 Mar;31:32-37. doi: 10.1016/j.preghy.2022.11.008. Epub 2022 Dec 5.

本文引用的文献

1
Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan.日本针对孕妇的抗 SARS-CoV-2 疫苗接种策略。
J Obstet Gynaecol Res. 2021 Jun;47(6):1958-1964. doi: 10.1111/jog.14748. Epub 2021 Mar 23.
2
Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection.少数族裔住院 COVID-19 感染患者的临床特征和死亡预测因素。
J Racial Ethn Health Disparities. 2022 Feb;9(1):335-345. doi: 10.1007/s40615-020-00961-x. Epub 2021 Feb 4.
3
Characteristics of COVID-19 patients admitted into two hospitals in sapporo, Japan: Analyses and insights from two outbreak waves.日本札幌两家医院收治的 COVID-19 患者的特征:两次疫情暴发期间的分析与见解。
Respir Investig. 2021 Mar;59(2):180-186. doi: 10.1016/j.resinv.2020.11.008. Epub 2021 Jan 1.
4
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.2020 年 10 月至 11 月英国 SARS-CoV-2 N501Y 突变株的早期传播能力评估。
Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
5
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort.美国队列中新型冠状病毒肺炎生物标志物与临床结局的关联。
Biomark Med. 2020 Aug;14(12):1091-1097. doi: 10.2217/bmm-2020-0309. Epub 2020 Jul 17.
6
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.2020 年韩国冠状病毒病疫情期间的接触者追踪。
Emerg Infect Dis. 2020 Oct;26(10):2465-2468. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16.
7
Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在新型冠状病毒肺炎中的应用
J Clin Med Res. 2020 Jul;12(7):448-453. doi: 10.14740/jocmr4240. Epub 2020 Jun 25.
8
Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies.妊娠作为流感病毒感染导致严重后果的危险因素:一项观察性研究的系统评价和荟萃分析
Vaccine. 2017 Jan 23;35(4):521-528. doi: 10.1016/j.vaccine.2016.12.012. Epub 2016 Dec 23.
9
Pneumonia in pregnancy.妊娠期肺炎
Crit Care Med. 2005 Oct;33(10 Suppl):S390-7. doi: 10.1097/01.ccm.0000182483.24836.66.